Biodegradation of Micropollutants and Prospects for Water and Wastewater Biotreatment

Comprehensive Biotechnology, Second Edition

Volumn 6, Issue , 2011, Pages 485-494

  Forrez, I ^a   Boon, N ^a   Verstraete, W ^a   Carballa, M ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Activated sludge; Co metabolism; Ecotoxicity; Endocrine disrupting compounds; Micropollutants; Nitrification; Pharmaceuticals and personal care products

Indexed keywords

EID: 85012861808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00535-3     Document Type: Chapter

References (63)

1. Andersen H., Siegrist H., Halling-Sorensen B., Ternes T.A. Fate of estrogens in a municipal sewage treatment plant. Environmental Science and Technology 2003, 37:4021-4026.
2. Auriol M., Filali-Meknassi Y., Tyagi R.D., et al. Endocrine disrupting compounds removal from wastewater, a new challenge. Process Biochemistry 2006, 41:525-539.
3. Batt A.L., Kim S., Aga D. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge. Environmental Science and Technology 2006, 40:7367-7373.
4. Bergink E.W., Kloosterboer H., van der Velden W.H.M., et al. Specificity of an estrogen binding protein in the human vagina compared with that of estrogen receptors in different tissues from different species. Steroids and Endometrial Cancer 1983, 77-84. Raven Press, New York. V.M. Jasonni (Ed.).
5. Bock E., Wagner M. Oxidation of inorganic nitrogen compounds as an energy source. The Prokaryotes 2006, 457-495. Springer, New York. M. Dworkin (Ed.).
6. Boxall A.B.A., Kolpin D.W., Sorensen B.H., Tolls J. Are veterinary medicines causing environmental risks?. Environmental Science and Technology 2003, 1:286A-294A.
7. Brusseau G.A., Hsien-Chang T., Hanson R.S., Wackett L.P. Optimization of trichloroethylene oxidation by methanotrophs and the use of a colorimetric assay to detect soluble methane monooxygenase activity. Biodegradation 1990, 1:19-29.
8. Cao N., Yang M., Zhang Y., et al. Evaluation of wastewater reclamation technologies based on in vitro and in vivo bioassays. Science of the Total Environment 2009, 407:1588-1597.
9. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
10. Chang S.W., Hyman M.R., Williamson K.J. Cooxidation of naphthalene and other polycyclic aromatic hydrocarbons by the nitrifying bacterium, Nitrosomonas europaea. Biodegradation 2002, 13:373-381.
11. Choubert J.M., Marquot A., Stricker A.E., et al. Maximum growth and decay rates of autotrophic biomass to simulate nitrogen removal at 10°C with municipal activated sludge plants. Water SA 2008, 34:71-76.
12. Clara M., Kreuzinger N., Strenn B., et al. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Research 2005, 39:97-106.
13. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: Agents of subtle change?. Environmental Health Perspectives 1999, 107:907-938.
14. De Gusseme B., Pycke B., Hennebel T., et al. Biological removal of 17α-ethinylestradiol by a nitrifier enrichment culture in a membrane bioreactor. Water Research 2009, 43:2493-2503.
15. Desbrow C., Routledge E.J., Brighty G.C., et al. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environmental Science and Technology 1998, 32:1549-1558.
16. Erguder T.H., Boon N., Wittebolle L., et al. Environmental factors shaping the ecological niches of ammonia-oxidizing archaea. FEMS Microbiology Reviews 2009, 33:855-869.
17. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicology 2006, 76:122-159.
18. Fiencke C., Bock E. Immunocytochemical localization of membrane-bound ammonia monooxygenase in cells of ammonia oxidizing bacteria. Archives of Microbiology 2006, 185:99-106.
19. Forrez I., Carballa M., Boon N., Verstraete W. Biological removal of 17α-ethinylestradiol (EE2) in an aerated nitrifying fixed bed reactor during ammonium starvation. Journal of Chemical Technology and Biotechnology 2009, 84:119-125.
20. Garric J., Vollat B., Nguyen D.K., et al. Ecotoxicological and chemical characterization of municipal wastewater treatment plant effluents. Water Science and Technology 1996, 33:83-91.
21. Gaulke L.S., Strand S.E., Kalhorn T.F., Stensel H.D. 17α-ethinylestradiol transformation via abiotic nitration in the presence of ammonia-oxidizing bacteria. Environmental Science and Technology 2008, 42:7622-7627.
22. Göbel A., McArdell C.S., Joss A., et al. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Science of the Total Environment 2007, 372:361-371.
23. Haiyan R., Shulan J., Ahmad N., et al. Degradation characteristics and metabolic pathway of 17α-ethinylestradiol by Sphingobacterium sp. JCR5. Chemosphere 2007, 66:340-346.
24. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., et al. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-394.
25. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Science of the Total Environment 1999, 225:109-118.
26. Hooper A.B., Vannelli T., Bergmann D.J., Arciero D.M. Enzymology of the oxidation of ammonia to nitrite by bacteria. Antonie Van Leeuwenhoek 1997, 71:59-67.
27. Hyman M.R., Murton I.B., Arp D.J. Interaction of ammonia monooxygenase from Nitrosomonas europaea with alkanes, alkenes, and alkynes. Applied and Environmental Microbiology 1988, 54:3187-3190.
28. Ikehata K., Naghashkar N.J., Ei-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review. Ozone-Science and Engineering 2006, 28:353-414.
29. Joss A., Zabczynski S., Gobel A., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Research 2006, 40:1686-1696.
30. Kidd K.A., Blanchfield P.J., Mills K.H., et al. Collapse of a fish population after exposure to a synthetic estrogen. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8897-8901.
31. Kim J.Y., Ryu K., Kim E.J., et al. Degradation of bisphenol-A and nonylphenol by nitrifying activated sludge. Process Biochemistry 2007, 42:1470-1474.
32. Kimura K., Amy G., Drewes J.E., et al. Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes. Journal of Membrane Science 2003, 227:113-121.
33. Klavarioti M., Mantzavinos D., Kassinos D. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environment International 2009, 35:402-417.
34. Klotz M.G., Alzerreca J., Norton J.M. A gene encoding a membrane protein exists upstream of the amoA/amoB genes in ammonia oxidizing bacteria: A third member of the amo operon?. FEMS Microbiology Letters 1997, 150:65-73.
35. Koops H.P., Pommerening-Roser A. Distribution and ecophysiology of the nitrifying bacteria emphasizing cultured species. FEMS Microbiology Ecology 2001, 37:1-9.
36. Laville N., Ait-Aissa S., Gomez E., et al. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
37. Levine A.D., Meyer M.T., Kish G. Evaluation of the persistence of micropollutants through pure-oxygen activated sludge nitrification and denitrification. Water Environment Research 2006, 78:2276-2285.
38. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: A review. Biodegradation 2009, 20:441-466.
39. Oppenheimer J., Stephenson R., Burbano A. Characterizing the passage of personal care products through wastewater treatment processes. Water Environment Research 2007, 79:2564-2577.
40. Pauwels B., Wille K., Noppe H., et al. 17α-ethinylestradiol cometabolism by bacteria degrading estrone, 17α-estradiol and estriol. Biodegradation 2008, 19:683-693.
41. Pinck C., Coeur C., Potier P., Bock E. Polyclonal antibodies recognizing the AmoB protein of ammonia oxidizers of the beta-subclass of the class Proteobacteria. Applied and Environmental Microbiology 2001, 67:118-124.
42. Purdom C.E., Hardiman P.A., Bye V.J., et al. Estrogenic effects of effluents from sewage treatment works. Chemical Ecology 1994, 8:275-285.
43. Ren Y.-X., Nakano K., Nomura M., et al. Effects of bacterial activity on estrogen removal in nitrifying activated sludge. Water Research 2007, 41(14):3089-3096.
44. Richardson S.D., Fasano F., Ellington J.J., et al. Occurrence and mammalian cell toxicity of iodinated disinfection byproducts in drinking water. Environmental Science and Technology 2008, 42:8330-8338.
45. Sacher F., Ehmann M., Gabriel S., et al. Pharmaceutical residues in the river Rhine - results of a one-decade monitoring programme. Journal of Environmental Monitoring 2008, 10:664-670.
46. Schwaiger J., Ferling H., Mallow U., et al. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part 1: Histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology 2004, 68:141-150.
47. Shi J., Fujisawa S., Nakai S., Hosomi M. Biodegradation of natural and synthetic estrogens by nitrifying activated sludge and ammonia-oxidizing bacterium Nitrosomonas europaea. Water Research 2004, 38:2323-2330.
48. Shi J.H., Suzuki Y., Lee B.D., et al. Isolation and characterization of the ethynylestradiol-biodegrading microorganism Fusarium proliferatum strain HNS-1. Water Science and Technology 2002, 45:175-179.
49. Snyder S.A., Villeneuve D.L., Snyder E.M., Giesy J.P. Identification and quantification of estrogen receptor agonists in wastewater effluents. Environmental Science and Technology 2001, 35:3620-3625.
50. Stalter D., Magdeburg A., Oehlmann J. Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery. Water Research 2010, 44:2610-2620.
51. Suárez S., Carballa M., Omil F., Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?. Reviews in Environmental Science and Biotechnology 2008, 7:125-138.
52. Taggart M.A., Cuthbert R., Das D., et al. Diclofenac disposition in Indian cow and goat with reference to Gyps vulture population declines. Environmental Pollution 2007, 147:60-65.
53. Ternes T., Joss A. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management 2007, IWA Publishing, London.
54. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Research 1998, 32:3245-3260.
55. Ternes T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology 2004, 38:392A-399A.
56. Triebskorn R., Casper H., Heyd A., et al. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 2004, 68:151-166.
57. Vader J.S., van Ginkel C.G., Sperling F., et al. Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 2000, 41:1239-1243.
58. Van Haandel A., van der Lubbe J. Handbook of Biological Waste Water Treatment: Design and Optimisation of Activated Sludge Systems 2007, Quist Publishing, Leidschendam.
59. Wick A., Fink G., Joss A., et al. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. Water Research 2009, 43:1060-1074.
60. Yi T., Harper W.P. The link between nitrification and biotransformation of 17?-ethinylestradiol. Environmental Science and Technology 2007, 47:4311-4316.
61. Yi T.W., Harper W.F., Holbrook R.D., Love N.G. Role of particle size and ammonium oxidation in removal of 17?-ethinyl estradiol in bioreactors. Journal of Environmental Engineering - ASCE 2006, 132:1527-1529.
62. Yoshimoto T., Nagai F., Fujimoto J., et al. Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates from activated sludge in wastewater treatment plants. Applied and Environmental Microbiology 2004, 70:5283-5289.
63. Zhang Y.J., Geissen S.U., Gal C. Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.